Caniphedrin 50 mg Tablets for Dogs
Active ingredient: Ephedrine Hydrochloride
Form
Tablet
Species
Manufacturer
VetViva Richter GmbH
VMD MA No.
57446/4020
The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Ephedrine Hydrochloride
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Caniphedrin 50 mg Tablets for Dogs — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.
The recommended starting dose is 2 mg ephedrine hydrochloride (corresponding to
1.64 mg of ephedrine) per kg bodyweight (BW), equivalent to 1 tablet per 25 kg BW,
per day during the first 10 days of treatment. The daily dose may be divided. Once
the desired effect has been achieved, the dose can be reduced to one half or less.
Based on the observed effect and taking into account the occurrence of adverse
effects, the individual dose should be adjusted to find the lowest effective dose. The
lowest effective dose should be maintained for long-term treatment. In case of a
relapse, the dose should be increased to 2 mg ephedrine hydrochloride per kg BW
AN: 01317/2024 & 01318/2024
again. Once the effective dose has been established, dogs should still be monitored
at regular intervals.
This tablet strength is not appropriate for dogs weighing less than 12.5 kg
(recommended starting dose of 2 mg/kg).
arrhythmia, hypertension), hyperthyroidism, diabetes mellitus, impaired renal function or
glaucoma.
Do not use concurrently with halogenated narcotics such as halothane or
methoxyflurane (see section 3.8).
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
AN: 01317/2024 & 01318/2024
Rare
(1 to 10 animals / 10 000 animals treated):
Rapid pulse rate
, Ventricular arrhythmia
;
Excitation
.
Undetermined frequency
(cannot be estimated from the available
data):
Tachycardia
, Atrial fibrillation
, Increased
heart rate
, Peripheral vasoconstriction
;
Not sleeping
, Anxiety
;
Muscle tremor
, Mydriasis
;
AN: 01317/2024 & 01318/2024
Pulmonary disorder (bronchodilatation and
decrease of mucus release in the
respiratory mucosal membranes)
;
Digestive tract hypomotility
.
These symptoms disappear following dose reduction or termination of treatment.
Due to the pharmacological properties of ephedrine these effects can occur at the
recommended therapeutic dose.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.
inappropriate urination.
In bitches less than 1 year old the possibility of anatomical disorders contributing to
incontinence should be considered prior to treatment.
It is important to identify any underlying disease causing Polyuria/Polydipsia (PU/PD)
which may be falsely diagnosed as urinary incontinence.
Special precautions for safe use in the target species:
The dog’s cardiovascular functionality should be carefully assessed before the start of
the treatment with the veterinary medicinal product and it should be periodically
monitored during the treatment.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to ephedrine should avoid contact with the veterinary
medicinal product.
Ephedrine hydrochloride could be toxic if ingested and ingestion may be fatal, especially
to children. Adverse effects may include insomnia and nervousness, dizziness,
headache, increased blood pressure, increased sweating and nausea.
To avoid accidental ingestion, particularly by a child, the veterinary medicinal product
must be administered out of the sight of children. Unused tablet parts should be returned
to the open blister space and inserted back into the carton and kept in a safe place out
of the sight and reach of children.
In case of accidental ingestion, most importantly by children, seek medical advice
immediately and show the package leaflet or the label to the physician.
It is strongly recommended that pregnant women should wear impermeable gloves
when handling the tablets.
Wash hands thoroughly after administration of the veterinary medicinal product.
Special precautions for the protection of the environment:
Not applicable.
administered together with methylxanthines and sympathomimetics.
Ephedrine may enhance glucocorticoid metabolism.
Concomitant use with MAO-inhibitors may cause hypertension.
Ephedrine may increase the risk for theophylline toxicity.
There is a risk of cardiac arrhythmia when combined with cardiac glycosides (e.g.
digoxin), quinine, tricyclic antidepressants and halogenated narcotics (see section
3.3).
Substances leading to an increase in pH of the urine are able to prolong the
excretion of ephedrine, which may lead to an increased risk of adverse reactions.
Substances leading to a decrease in pH of the urine are able to accelerate the
excretion of ephedrine, which may lead to decreased efficacy.
Vascular constrictions can occur after concomitant treatment with ergot alkaloids and
oxytocin.
Sympatholytics may decrease the efficacy of ephedrine.
or freeze.
Unused divided tablets should be returned to the blister and used in the subsequent
dose.
4.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Other Products Containing Ephedrine Hydrochloride
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
VetBox Flea & Worm Protection for Dogs
Vet-founded monthly parasite subscription. Flea, tick and worm protection delivered to your door. Founded by Dr Will Woodley, protecting 30,000+ pets.
We may earn a small commission if you purchase through these links, at no extra cost to you.
Related Medications
Alzane 5 mg/ml, Solution for Injection for Dogs and Cats
POM-VAtipamezole Hydrochloride
Antisedan 5 mg/ml Solution for Injection
POM-VAtipamezole Hydrochloride
Atipam 5.0 mg/ml, Solution for Injection for Cats and Dogs
POM-VAtipamezole Hydrochloride
Atipazole 5 mg/ml Solution for Injection for Dogs and Cats
POM-VAtipamezole Hydrochloride
Bonqat 50 mg/ml Oral Solution for Cats
POM-VPregabalin
Bonqat 50 mg/ml Oral Solution for Cats
POM-VPregabalin
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.